Management and Treatment of Type 2 Diabetes
Saad Masood Butt
Abstract
Diabetes is a diseas caused by insufficient insulin production by the pancreas. Diabetic people aged 18 and older accounted for 8.5% of the total adult population in 2014. From 2000 to 2010, the early death rate from diabetes was reduced in high-income nations, but then grew again from 2010 to 2016. Premature mortality from diabetes rose in low- and middle-income nations across both time periods. Noncommunicable illnesses (cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes) between the ages of 30 and 70 have declined by 18 percent worldwide since 2020. Cardiovascular events are markedly increased in people with diabetes. Diabetes treatment must be based on a thorough understanding of the disease's pathophysiology. To treat type 1 diabetics, insulin is necessary since insulin production is impaired. When insulin secretion and action are both impaired in people with type 2 diabetes, treatment becomes more difficult. As a result, the patient's stage of the disease and personal characteristics will influence the type of treatment he or she receives. Type 2 diabetes management and treatment objectives are discussed in this research.